Clinical studies in MM patients and other patients with advanced cancer showed low biological response (low IFN-γ secretion) of iNKTs which was correlated to a dysfunction of the cells [5], [8], [16], [17], [18]. The gene discussed is IFNG; the disease is Miyoshi myopathy.